Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Legislation
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
2022 Savings Report
2022 Interactive State Savings Map
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
Interactive Savings Map
- Find out how much your state saved from generic and biosimilar medicines.
Learn More
Close
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
May 2, 2022
| Monét Stanford
Generics Drive Savings Yet Patients Continue to Pay More
Blog
Apr 19, 2022
| Monét Stanford
As Health Care Spending in US Projected to Increase, Generics and Biosimilars Expected to Moderate Growth
Blog
Apr 19, 2022
| Monét Stanford
Challenges & Solutions for Prescription Drug Savings Identified by MedPAC
Blog
Apr 8, 2022
| Steven Selde
HHS OIG Report Demonstrates Need for Changes to Part D to Increase Biosimilar Use
Blog
Mar 30, 2022
| Erica Klinger
KC is Enjoying Life— “a Pretty Good Deal” on Prescriptions
Blog
Mar 24, 2022
| Sara Skubikowski
The Savings Add Up for Patients
Blog
Mar 23, 2022
| Erica Klinger
Greg is Treating His Ulcerative Colitis, and Enjoying a Slice or Two
Blog
Mar 18, 2022
| Monét Stanford
Senate Finance Hearing Highlights Ways to Reduce Drug Prices without Harming Patients
Blog
Mar 15, 2022
| Erica Klinger
Eileen is Singing, Dancing and Taking Care of Herself with Biosimilars
Blog
Mar 7, 2022
| Joanne Duncan
Women’s History Month: Honoring Yesterday’s and Today’s Leaders
Blog
Feb 23, 2022
| Aquera Agee
Access! 2022: Recapping AAM’s Annual Meeting
Blog
Feb 16, 2022
| Jewel Smith
Black History Month: 10 Pioneers to Celebrate
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Legislation
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
2022 Savings Report
2022 Interactive State Savings Map
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action